Integrating AI-Powered Digital Pathology and Imaging Mass Cytometry Identifies Key Classifiers of Tumor Cells, Stroma, and Immune Cells in Non-Small Cell Lung Cancer
Overview
Authors
Affiliations
Significance: Leveraging artificial intelligence-powered H&E analysis integrated with hi-plex imaging mass cytometry provides insights into the tumor ecosystem and can translate tumor features into classifiers to predict prognosis, genotype, and therapy response.
Ocana A, Pandiella A, Privat C, Bravo I, Luengo-Oroz M, Amir E Biomark Res. 2025; 13(1):45.
PMID: 40087789 DOI: 10.1186/s40364-025-00758-2.
Lau M, Borowsky J, Vayrynen J, Haruki K, Zhao M, Dias Costa A PLoS Comput Biol. 2025; 21(2):e1012707.
PMID: 39965007 PMC: 11849983. DOI: 10.1371/journal.pcbi.1012707.
Artificial intelligence in lung cancer: current applications, future perspectives, and challenges.
Huang D, Li Z, Jiang T, Yang C, Li N Front Oncol. 2025; 14:1486310.
PMID: 39763611 PMC: 11700796. DOI: 10.3389/fonc.2024.1486310.
Making space for spatial biology in the clinic.
Nat Biotechnol. 2025; 43(1):1-2.
PMID: 39762531 DOI: 10.1038/s41587-024-02543-2.
Defining precancer: a grand challenge for the cancer community.
Faupel-Badger J, Kohaar I, Bahl M, Chan A, Campbell J, Ding L Nat Rev Cancer. 2024; 24(11):792-809.
PMID: 39354069 DOI: 10.1038/s41568-024-00744-0.